Replies to post #234 on EyePoint Pharmaceuticals Inc (EYPT)

[LongRun8]

I'm holding. Hopefully the financials will be ok, given that they just had a secondary. Either way, it's a small cap biopharm, so I'm not going to go crazy myself about financials and sell my shares that are green now, as I believe in their products. How about you?

Good luck.

[Guynms26]

I just got this email and thought I would share from the Weiss Watchdog group..

As you've requested, the Weiss Watchdog is monitoring the rating of a company for you, and we're writing to let you know that the rating of that company has just changed. Here it is...

AllianzGI NFJ Small Cap Value Inst (PSVIX)

Was Upgraded to B+ from B

This is the INVESTMENT rating, designed to measure the risk and reward of owning the investment itself. So please do not confuse it with our FINANCIAL STRENGTH Rating which would evaluate the financial safety of the company overall.

The new rating is B+. This means that The mutual fund has a good track record for balancing perfor! mance with risk. Compared to other mutual funds, it has achieved above-average returns given the level of risk in its underlying investments. While the risk-adjusted performance of any mutual fund is subject to change, we believe that this fund has proven to be a good investment in the recent past.

+ (Plus Sign) - An indication that the fund is in the top third of its letter grade.

Any upgrade, no matter how small, is a good sign. But in our view, this particular upgrade is not significant enough to warrant any new action on your part.

As always, we will continue to monitor this company for you. And we'll let you know as soon as there's any further change.

We trust that covers all the main issues. Stay tuned. We'll send you another e-mail as soon as there's any rating change in any company on your Watchlist.

Best wishes,

The Weiss Watchdog Team